Positron emission tomography in aging and dementia: effect of cerebral atrophy.
Publication/Presentation Date
4-1-1987
Abstract
The spatial resolution of current positron emission tomography (PET) scanners does not allow a distinction between cerebrospinal fluid (CSF) containing spaces and contiguous brain tissue. Data analysis strategies which therefore purport to quantify cerebral metabolism per unit mass brain tissue are in fact measuring a value which may be artifactually reduced due to contamination by CSF. We studied cerebral glucose metabolism (CMRglc) in 17 healthy elderly individuals and 24 patients with Alzheimer's dementia using [18F]fluorodeoxyglucose and PET. All subjects underwent x-ray computed tomography (XCT) scanning at the time of their PET study. The XCT scans were analyzed volumetrically, in order to determine relative areas for ventricles, sulci, and brain tissue. Global CMRglc was calculated before and after correction for contamination by CSF (cerebral atrophy). A greater increase in global CMRglc after atrophy correction was seen in demented individuals compared with elderly controls (16.9% versus 9.0%, p less than 0.0005). Additional preliminary data suggest that volumetric analysis of proton-NMR images may prove superior to analysis of XCT data in quantifying the degree of atrophy. Appropriate corrections for atrophy should be employed if current PET scanners are to accurately measure actual brain tissue metabolism in various pathologic states.
Volume
28
Issue
4
First Page
431
Last Page
437
ISSN
0161-5505
Published In/Presented At
Chawluk, J. B., Alavi, A., Dann, R., Hurtig, H. I., Bais, S., Kushner, M. J., Zimmerman, R. A., & Reivich, M. (1987). Positron emission tomography in aging and dementia: effect of cerebral atrophy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 28(4), 431–437.
Disciplines
Medicine and Health Sciences
PubMedID
3494824
Department(s)
Department of Medicine
Document Type
Article